Aims & Scope
Current Enzyme Inhibition aims to publish original research, full-length/mini review and letter articles in all the latest and outstanding developments on enzyme inhibition studies. The coverage includes the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Current Enzyme Inhibition is an essential journal for every pharmaceutical researcher and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.
Cabell's Directory, Cambridge Scientific Abstracts (CSA)/ProQuest, Chemical Abstracts Service/SciFinder, ChemWeb, CNKI Scholar, Dimensions, EBSCO, EMBASE, EMBiology, Genamics JournalSeek, Google Scholar, J-Gate, JournalTOCs, MediaFinder®-Standard Periodical Directory, Open Abstracts (I4OA), PubsHub, QOAM, Scilit, Scopus, Suweco CZ, TOC Premier, and Ulrich's Periodicals Directory.
Current Enzyme Inhibition Journal was launched in 2005. Dr. Claudiu T. Supuran serves as the Editor-in-Chief of the journal.
Quick processing and publication of the submitted papers. The manuscript will be published online within 20 days of final acceptance.
30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published.
Multiple issue copies at discounted rates.
"Current Enzyme Inhibition is an important review journal that describes recent developments in enzyme inhibition studies and is of great value to pharmaceutical and medicinal chemists."
Richard B. Silverman
Northwestern Univ., USA
We are very satisfied by the services of Bentham Science Publishers; due to which we publish the majority of our papers with you.
(Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy, Timisoara, Romania.)